| abstract |
For the treatment of idiopathic (acute) or chronic interstitial pneumonia, containing lecithinized superoxide dismutase (hereinafter referred to as PC-SOD), which effectively exhibits the action of superoxide dismutase (SOD), as an active ingredient The following general formula (I): SOD ′ (Q−B) m (I) (In the formula, SOD ′ represents a residue of superoxide dismutase, Q represents a chemical bridge, B represents a residue of lysolecithin having a hydroxyl group at the 2-position of glycerol excluding a hydrogen atom of the hydroxyl group, m Is the average binding number of lysolecithin to one molecule of superoxide dismutase, and represents an integer of 1 or more) An inhalant characterized by comprising PC-SOD represented by |